Browse resources

Topic: Immunization financing

Total results with these characteristics: 128

Page 1 of 6  
1
2
3
4
next ›

Advance Market Commitments for Vaccines

This informative fact sheet provides a definition of Advance Market Commitments as a potential financing mechanism for bringing new vaccines to the developing world and also outlines World Health Organization's position on the mechanism.

Author: World Health Organization

Published: 2006

Andhra Pradesh: Building a Model Immunization System

This report discusses the work of PATH's Children's Vaccine Program and the Indian state of Andhra Pradesh to build a model immunization program, including the incorporation of hepatitis B vaccine into the childhood vaccination program.

Author: PATH

Published: 2004

The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean: A Review of the Evidence and a Preliminary Economic Analysis

This report estimates the burden and costs of pneumococcal disease in Latin America and the Caribbean in order to inform national health authorities about disease burden and the economic value of implementing a pneumococcal …

Author: Sabin Vaccine Institute

Published: 2007

A Call to Action for the New Decade of Vaccines

This article, published in The Lancet, argues that there is a moral imperative to make vaccines widely available on an equitable basis. The authors lay out a call to action for the new decade of vaccines, which embraces four key elements. …

Author: Moxon ER, Das P, Greenwood B, et al.

Published: 2011

Calling the Shots: A Review of Global Immunisation Initiatives and Future Priorities

This report reviews the successes and challenges of current global immunization programs, with a particular focus on: pneumonia, diarrheal disease, polio, measles, and rubella. It argues that while there is much to be applauded, there is a funding …

Author: Royal College of Paediatrics and Child Health

Published: 2013

Cambodia: "Coverage Improvement Planning" Pays Off

This report discusses the work of PATH's Children's Vaccine Program and the Australian International Health Institute of the University of Melbourne to provide technical assistance with immunization programming to Cambodia, including the …

Author: PATH

Published: 2004

Can We Defeat Meningococcal Disease in Low and Middle Income Countries?

This article, published in Vaccine, discusses the challenges of achieving control of meningococcal disease in low- and middle-income countries. The authors argue that in low-income countries the main challenge is a lack of sufficient epidemiological …

Author: Greenwood B, Chiarot E, MacLennan CA, O'Ryan M

Published: 2012

Cervical Cancer, Human Papillomavirus (HPV), and HPV vaccines: Key Points for Policy-Makers and Health Professionals

HPV vaccines address a critical public health need, and will be an important element of a comprehensive cervical cancer control strategy. Ensuring universal access to HPV vaccination, screening, and treatment services will be key to reducing the …

Author: World Health Organization

Published: 2008

Cervical Cancer Prevention and HPV Vaccines

This fact sheet outlines the types of support the GAVI Alliance offers for the introduction of human papillomavirus (HPV) vaccines in eligible countries. It also links to the specific requirements for country applications.

Author: GAVI Alliance

Published: 2014

Comparative Evaluation of the Potential Impact of Rotavirus Versus HPV Vaccination in GAVI-Eligible Countries: A Preliminary Analysis Focused on the Relative Disease Burden

This article, published in BMC Infectious Diseases, reports on a study that aimed to provide early insight into how the comparative impact of different new vaccines could be assessed in resource-poor settings with respect to affordability, …

Author: Kim SY, Sweet S, Chang J, Goldie SJ

Published: 2011

Comparative Review of Three Cost-Effectiveness Models for Rotavirus Vaccines in National Immunization Programs: A Generic Approach Applied to Various Regions in the World

This article, published in BMC Medicine, critically reviews available cost-effectiveness models for rotavirus vaccination, comparing their designs using a standardized approach and studying the similarities and differences in cost-effectiveness …

Author: Postma MJ, Jit M, Rozenbaum MH, Standaert BA, Tu HA, Hutubessy RCW

Published: 2011

A Cost Effectiveness and Capacity Analysis for the Introduction of Universal Rotavirus Vaccination in Kenya: Comparison Between Rotarix and RotaTeq Vaccines

The authors of this article, published in PLoS ONE, applied cost-effectiveness modeling and a cold-chain impact assessment to aid decision-making on rotavirus vaccine introduction in Kenya. They conclude that use of either vaccine is cost-effective, …

Author: van Hoek AJ, Ngama M, Ismail A, et al.

Published: 2012

Cost Effectiveness of Rotavirus Vaccines and Other Interventions for Diarrhoeal Diseases: Meeting Report 2006

This report from the WHO's Weekly Epidemiologic Record summarizes a meeting convened by PATH, WHO, and the US Centers for Disease Control and Prevention (CDC) on the economic burden of rotavirus disease and cost-effectiveness of vaccines. The …

Author: World Health Organization

Published: 2006

The Cost of Immunization Programs in the Next 10 Years

This paper summarizes the results of a WHO/UNICEF study on the potential impact of immunization over the next decade and the financing required for immunization activities in the 72 poorest countries of the world.

Author: World Health Organization

Published: 2006

Cost-Effectiveness and Economic Benefits of Vaccines in Low- and Middle-Income Countries: A Systematic Review

This review, published in Vaccine, documents the available evidence showing that vaccination in low- and middle-income countries brings important economic benefits. The cost-effectiveness studies reviewed suggest to policy makers that vaccines are …

Author: Ozawa S, Mirelman A, Stack ML, Walker DG, Levine OS

Published: 2012

Cost-Effectiveness and Potential Impact of Rotavirus Vaccination in the United States

This study, published in the journal Pediatrics, examines the costs and benefits of routine rotavirus vaccination for infants in the US, using a hypothetical cohort of unvaccinated infants. Researchers determined that, at current prices, …

Author: Widdowson MA, Meltzer MI, Zhang X, et al.

Published: 2007

Cost-Effectiveness of a New Rotavirus Vaccination Program in Pakistan: A Decision Tree Model

This article, published in Vaccine, reports on the expected public health impact of a national rotavirus vaccination program in Pakistan by performing a cost-effectiveness study from the perspective of the health care system. Across a range of …

Author: Patel HD, Roberts ET, Constenla DO

Published: 2013

Cost-Effectiveness of Childhood Rotavirus Vaccination in Taiwan

This paper, published in the journal Vaccine, investigates whether routine infant immunization with either currently licensed rotavirus vaccine could be cost-effective in Taiwan. The authors modeled specific disease outcomes …

Author: Wu CL, Yang YC, Huang LM, Chen KT

Published: 2009

Cost-effectiveness of Conjugate Meningococcal Vaccination Strategies in the United States

This article, published in the journal Pediatrics, discusses a study to evaluate and compare the projected health and economic impact of meningococcal conjugate A/C/Y/W-135 (MCV-4) vaccination of adolescents, toddlers, and infants in the United …

Author: Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team

Published: 2005

Cost-Effectiveness of Female Human Papillomavirus Vaccination in 179 Countries: A PRIME Modelling Study

This article, published in The Lancet Global Health, reports on a modeling study that assessed the cost-effectiveness and health effects of vaccinating girls against human papillomavirus (HPV) before sexual debut in terms of burden of cervical …

Author: Jit M, Brisson M, Portnoy A, Hutubessy R

Published: 2014

Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …

Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R

Published: 2008

Cost-Effectiveness of Japanese Encephalitis Vaccination

This fact sheet summarizes methods and results of cost-effectiveness analyses performed by PATH and its partners to determine the economic implications of introducing JE vaccine programs. The fact sheet is an excerpt from a larger, comprehensive …

Author: PATH

Published: 2009

The Cost-Effectiveness of Rotavirus Vaccination in Armenia

This article, published in Vaccine, evaluates the cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(R)® using a multiple birth cohort model. The model considered the cost and health implications of …

Author: Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L

Published: 2011

Cost-Effectiveness of Routine Immunization to Control Japanese Encephalitis in Shanghai, China

From the Bulletin of the World Health Organization, this article investigates the cost-effectiveness of JE immunization in China and demonstrates that a JE immunization program can be a cost-saving intervention for countries.

Author: Ding D, Kilgore PE, Clemens JD, Liu W, Xu Z

Published: 2003

Costs and Impact of Meningitis Epidemics for the Public Health System in Burkina Faso

Epidemic meningococcal meningitis remains a serious health threat in the African meningitis belt. New meningococcal conjugate vaccines are relatively costly and their efficiency will depend on cost savings realized from no longer having to respond …

Author: Colombini A, Badolo O, Gessner BD, Jaillard P, Seini E, Da Silva A

Published: 2011

Page 1 of 6  
1
2
3
4
next ›